✦ LIBER ✦

Hungarian yeshivot, Lithuanian yeshivot and Joseph Ben-David

✍ Scribed by Shaul Stampfer

Book ID: 105537247
Publisher: Springer
Year: 1997
Tongue: English
Weight: 689 KB
Volume: 11
Category: Article
ISSN: 0334-701X
DOI: 10.1007/bf02335361

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Joseph Ben-David's Hungary and Mendelsso

Joseph Ben-David's Hungary and Mendelssohn's Berlin

✍ Steven Lowenstein 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 270 KB

Pharmacokinetic interaction between dilt

Pharmacokinetic interaction between diltiazem and amiodarone in the dog

✍ Joseph Ben David; Meir Bialer 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 312 KB 👁 2 views

The pharmacokinetic interaction between diltiazem and amiodarone was investigated in dogs. In the presence of amiodarone, diltiazem's AUC values were sigmfkantly increased and its total body clearance and volume of distribution at steady-state significantly decreased. This study indicates that cardi

Antibodies to immunoglobulin heavy chain

Antibodies to immunoglobulin heavy chain variable regions protect helper cells from specific suicide by radiolabeled antigen

✍ Joseph Puri; Yinon Ben-Neriah; David Givol; Peter Lonai 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 452 KB

The antigen-binding receptor of helper T cells was studied by radioactive antigencaused suicide in vitro. Purified antibodies to immunoglobulin variable regions, obtained from sera of rabbits immunized with isolated VH and VL fragments of mouse myeloma proteins (MOPC 315, XRPC 25), were used to inhi

Criteria to assess in vivo performance o

Criteria to assess in vivo performance of sustained release products: Application to diltiazem formulations

✍ Meir Bialer; Sherbel Sussan; Omar Abu Salach; Haim D. Danenberg; Joseph Ben-Davi 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 578 KB

Pharmacokinetic analysis of two new sust

Pharmacokinetic analysis of two new sustained-release products of diltiazem designed for twice-and once-daily treatment

✍ Meir Bialer; Salim Hadad; Gershon Golomb; Shimon Barel; Emil Samara; Omar Abu Sa 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 409 KB 👁 2 views

The pharmacokinetics of two new sustained-release (SR) products of diltiazem, Dilapress 120 mg tablets and Dilapress 240 mg tablets, was analysed and characterized in three different studies, in comparison to the following diltiazem SR formulations: Cardizem Retard, Cardizem SR, and Cardizem CD. Dil

Screening for Lrrk2 G2019S and clinical

Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families

✍ Lianna Ishihara; Rachel A. Gibson; Liling Warren; Rim Amouri; Kelly Lyons; Cathe 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Mutations in the leucine-rich repeat kinase-2 gene (LRRK2) are responsible for some forms of familial as well as sporadic Parkinson's disease (PD). The purpose of this study was to examine the frequency of a single pathogenic mutation (6055G > A) in the kinase domain of this gene in United States an